CN105342939A - Disinfectant bath wash capable of reducing operative incision infection and preparation technology of disinfectant bath wash - Google Patents
Disinfectant bath wash capable of reducing operative incision infection and preparation technology of disinfectant bath wash Download PDFInfo
- Publication number
- CN105342939A CN105342939A CN201510931588.7A CN201510931588A CN105342939A CN 105342939 A CN105342939 A CN 105342939A CN 201510931588 A CN201510931588 A CN 201510931588A CN 105342939 A CN105342939 A CN 105342939A
- Authority
- CN
- China
- Prior art keywords
- bath foam
- disinfectant
- sterilization bath
- agent
- infection according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses disinfectant bath wash capable of reducing operative incision infection and a preparation technology of the disinfectant bath wash. The disinfectant bath wash is prepared from the following components in percentage by mass: 0.2 percent to 3 percent of disinfectant, 0.01 percent to 13 percent of collaborative sterilant, 2 percent to 10 percent of surfactant, 0.01 percent to 2 percent of humectant, 0.5 percent to 20 percent of thickener, 0.01 percent to 2 percent of acidity regulator and the balance of water. According to the disinfectant bath wash disclosed by the invention, chlorhexidine gluconate is selected as a main disinfection component of the disinfectant bath wash, the probability of the surgical operative incision infection is reduced, and bacterial resisting and inhibiting can be continuously carried out on an operative incision.
Description
Technical field
The invention belongs to disinfectant solution preparing technical field, be specifically related to a kind of the sterilization bath foam and the preparation technology thereof that reduce surgery cut infection.
Background technology
Surgical site infection (SSI) refers to without postoperative 30 days of implant, and have the implant infection relevant with operation that be that occur in postoperative 1 year, comprise surgery cut infection, adjacent organ and lacuna infect.SSI is one of postoperative modal complication, occupies the 3rd of hospital infection, accounts for the 14%-16% of nosocomial infections of inpatients.The method reducing postoperative wound infection has a lot, and wherein preoperative use is reduce the directly the easiest method of surgery cut infection containing the sterilization bath foam shower of chlorhexidine gluconate.
According to relevant, chlorhexidine gluconate disinfectant solution continuous skin antibacterial time sustainable 192h, the zest of chlorhexidine gluconate is little compared with chlorhexidine acetate, good stability.Preoperative use 2% chlorhexidine gluconate is extremely important, should clean patient skin before surgical sterilizing, removes dirt and reduces quantity in bacterium as far as possible, prophylaxis of microbial can move to operative region.
Summary of the invention
The invention provides a kind of the sterilization bath foam and the preparation technology thereof that reduce surgery cut infection, with prevention and corntrol surgical site infection problem.
The technical solution adopted for the present invention to solve the technical problems is:
Reduce a sterilization bath foam for surgery cut infection, be made up of disinfectant, Synergistic biocidal agent, surfactant, wetting agent, thickening agent, acidity regulator and water, wherein the service property (quality) percentage ratio of each component is disinfectant 0.2%-3%; Synergistic biocidal agent 0.01%-13%; Surfactant 2%-10%; Wetting agent 0.01%-2%; Thickening agent 0.5%-20%; Acidity regulator 0.01%-2%; Surplus is water.
Above-mentioned disinfectant is chlorhexidine gluconate, chlorhexidine acetate, triclosan, polyhexamethylene guanidine or poly hexamethylene biguanide, first-selected chlorhexidine gluconate.
Above-mentioned Synergistic biocidal agent is carboxymethyl chitosan.
Above-mentioned surfactant is fatty alcohol-polyoxyethylene ether, polyol ester, polyol ester polyoxyethylene ether or alkyl polyglucoside, and first-selected alkyl polyglucoside is as surfactant.
Above-mentioned wetting agent is vitamin E, propylene glycol, glycerol, Polyethylene Glycol, hyaluronic acid or Aloe, first-selected Aloe.
Above-mentioned thickening agent is CMC, thickening agent 638, thickening agent 658 or compound recipe thickening agent 698, first-selected compound recipe thickening agent 698.
Above-mentioned acidity regulator is lactic acid, malic acid or citric acid, first-selected citric acid.
The present invention sterilizes in body wash liquid formula:
Chlorhexidine gluconate: chlorhexidine has another name called chlorhexidine is biguanides disinfectant, is the safe disinfection agent that a kind of toxicity, corrosivity and zest are all very low.For external broad-spectrum antibacterial, bactericide, all have very strong antibacterial, sterilizing ability to Gram-negative and gram-positive bacterium, be a kind of cationic germicide, stock solution is 20% aqueous solution.
Carboxymethyl chitosan is one of higher derivative of chitosan, is obtained in the basic conditions by chitosan with chloroacetate reaction.Carboxymethyl chitosan is a kind of polyampholyte, has good water solublity, film property, moisturizing water-retaining property, antibiotic property and extremely strong heavy metal chelating effect.Carboxymethyl chitosan performance of keeping humidity is good, and its performance of keeping humidity and hyaluronic acid are quite, all highly stable within the scope of PH widely.Carboxymethyl chitosan does not have Intradermal zest, does not have cytotoxicity, possesses good biological safety.Adding carboxymethyl chitosan in this product can coordinate chlorhexidine gluconate collaborative anti-antibacterial, makes the anti-antibacterial time longer;
Alkyl polyglucoside is as a kind of environmental protection surfactant being derived from renewable plant material, nontoxic, gentle, do not stimulate, fully biodegradable.Alkyl polyglucoside is non-stimulated to eyes, have soft effect to skin, and its advantage is: foaming characteristic is good, and foaming abundancy is fine and smooth.Safety, thickening, thickening, detergency are remarkable.Alkyl polyglucoside has the antibacterial activity of wide spectrum, and to gram negative bacteria, positive bacteria and fungus, alkyl polyglucoside has antibacterial activity;
Compound recipe thickening agent 698, this product is nontoxic, non-irritating non-ionic surface active agent, and thickening properties is good, can the non-ionic surface active agent such as APG composite, there is excellent foaming power, washing force and sterilizing power;
Aloe: vegetal wetting agent, because Aloe juice contains mucopolysaccharide (being similar to hyaluronic acid), therefore has well lubrication and moisture-keeping function
The above-mentioned preparation technology reducing the sterilization bath foam of surgery cut infection, concrete steps, for getting Purified Water q. s in emulsion tank, are heated to 35 DEG C-40 DEG C, add surfactant and stir 20 minutes, be then cooled to room temperature.Add disinfectant and Synergistic biocidal agent, stir 15 minutes, add thickening agent, stir 20 minutes, measure the pH value of solution, slowly add acidity regulator, make the pH value of solution be 6-7, finally add wetting agent extracting solution and stir 20 minutes, can reduce the sterilization bath foam of operative incision.
Sterilization bath foam of the present invention select glucose saccharic acid chlorhexidine as sterilization bath foam main disinfection composition, reduce the probability of infected surgical incisions in nine, can to operation cutting part continue carry out anti-antibacterial.
Detailed description of the invention
Reduce a sterilization bath foam for surgery cut infection, be made up of disinfectant, Synergistic biocidal agent, surfactant, wetting agent, thickening agent, acidity regulator and water, wherein the service property (quality) percentage ratio of each component is disinfectant 0.2%-3%; Synergistic biocidal agent 0.01%-13%; Surfactant 2%-10%; Wetting agent 0.01%-2%; Thickening agent 0.5%-20%; Acidity regulator 0.01%-2%; Surplus is water.
Above-mentioned disinfectant is chlorhexidine gluconate, chlorhexidine acetate, triclosan, polyhexamethylene guanidine or poly hexamethylene biguanide, first-selected chlorhexidine gluconate.
Above-mentioned Synergistic biocidal agent is carboxymethyl chitosan.
Above-mentioned surfactant is fatty alcohol-polyoxyethylene ether, polyol ester, polyol ester polyoxyethylene ether or alkyl polyglucoside, and first-selected alkyl polyglucoside is as surfactant.
Above-mentioned wetting agent is vitamin E, propylene glycol, glycerol, Polyethylene Glycol, hyaluronic acid or Aloe, first-selected Aloe.
Above-mentioned thickening agent is CMC, thickening agent 638, thickening agent 658 or compound recipe thickening agent 698, first-selected compound recipe thickening agent 698.
Above-mentioned acidity regulator is lactic acid, malic acid or citric acid, first-selected citric acid.
The present invention sterilizes in body wash liquid formula:
Chlorhexidine gluconate: be a kind of cationic germicide is 20% aqueous solution;
Carboxymethyl chitosan is one of higher derivative of chitosan, is obtained in the basic conditions by chitosan with chloroacetate reaction.Carboxymethyl chitosan is a kind of polyampholyte, has good water solublity, film property, moisturizing water-retaining property, antibiotic property and extremely strong heavy metal chelating effect.Carboxymethyl chitosan performance of keeping humidity is good, and its performance of keeping humidity and hyaluronic acid are quite, all highly stable within the scope of PH widely.Carboxymethyl chitosan does not have Intradermal zest, does not have cytotoxicity, possesses good biological safety.Adding carboxymethyl chitosan in this product can coordinate chlorhexidine gluconate collaborative anti-antibacterial, makes the anti-antibacterial time longer;
Alkyl polyglucoside is as a kind of environmental protection surfactant being derived from renewable plant material, nontoxic, gentle, do not stimulate, fully biodegradable.Alkyl polyglucoside is non-stimulated to eyes, have soft effect to skin, and its advantage of A is: foaming characteristic is good, and foaming abundancy is fine and smooth.Safety, thickening, thickening, detergency are remarkable.Alkyl polyglucoside has the antibacterial activity of wide spectrum, and to gram negative bacteria, positive bacteria and fungus, alkyl polyglucoside has antibacterial activity;
Compound recipe thickening agent 698, this product is nontoxic, non-irritating non-ionic surface active agent, and thickening properties is good, can the non-ionic surface active agent such as APG composite, there is excellent foaming power, washing force and sterilizing power;
Aloe: vegetal wetting agent, because Aloe juice contains mucopolysaccharide (being similar to hyaluronic acid), therefore has well lubrication and moisture-keeping function
The above-mentioned sterilization bath foam reducing surgery cut infection, concrete steps, for getting Purified Water q. s in emulsion tank, are heated to 35 DEG C-40 DEG C, add Surfactants Alkyl and stir 20 minutes, be then cooled to room temperature.Add disinfectant chlorhexidine gluconate, stir 15 minutes, add compound recipe thickening agent 698, stir 20 minutes, measure the pH value of solution, slowly add acidity regulator citric acid, make the pH value of solution be 6-7, finally add wetting agent Aloe extraction solution and stir 20 minutes, can reduce the sterilization bath foam of operative incision.
Claims (14)
1. one kind can be reduced the sterilization bath foam of surgery cut infection, it is characterized in that being made up of disinfectant, Synergistic biocidal agent, surfactant, wetting agent, thickening agent, acidity regulator and water, wherein the service property (quality) percentage ratio of each component is disinfectant 0.2%-3%; Synergistic biocidal agent 0.01%-13%; Surfactant 2%-10%; Wetting agent 0.01%-2%; Thickening agent 0.5%-20%; Acidity regulator 0.01%-2%; Surplus is water.
2. the sterilization bath foam reducing surgery cut infection according to claim 1, is characterized in that disinfectant is chlorhexidine gluconate, chlorhexidine acetate, triclosan, polyhexamethylene guanidine or poly hexamethylene biguanide, first-selected chlorhexidine gluconate.
3. the sterilization bath foam reducing surgery cut infection according to claim 1, is characterized in that Synergistic biocidal agent is carboxymethyl chitosan.
4. the sterilization bath foam reducing surgery cut infection according to claim 1, is characterized in that surfactant is fatty alcohol-polyoxyethylene ether, polyol ester, polyol ester polyoxyethylene ether or alkyl polyglucoside.
5. the sterilization bath foam reducing surgery cut infection according to claim 1, is characterized in that wetting agent is vitamin E, propylene glycol, glycerol, Polyethylene Glycol, hyaluronic acid or Aloe.
6. the sterilization bath foam reducing surgery cut infection according to claim 1, is characterized in that thickening agent is CMC, thickening agent 638, thickening agent 658 or compound recipe thickening agent 698.
7. the sterilization bath foam reducing surgery cut infection according to claim 1, is characterized in that acidity regulator is lactic acid, malic acid or citric acid.
8. the sterilization bath foam reducing surgery cut infection according to claim 2, is characterized in that disinfectant is chlorhexidine gluconate.
9. the sterilization bath foam reducing surgery cut infection according to claim 4, is characterized in that surfactant is alkyl polyglucoside.
10. the sterilization bath foam reducing surgery cut infection according to claim 5, is characterized in that wetting agent is Aloe.
The 11. sterilization bath foam reducing surgery cut infection according to claim 6, is characterized in that thickening agent is compound recipe thickening agent 698.
The 12. sterilization bath foam reducing surgery cut infection according to claim 7, is characterized in that acidity regulator is citric acid.
13. preparation methoies reducing the sterilization bath foam of surgery cut infection according to claim 1, is characterized in that getting Purified Water q. s in emulsion tank, heat to 35 DEG C-40 DEG C, add surfactant and stir 20 minutes, be then cooled to room temperature.
14. add disinfectant and Synergistic biocidal agent, stir 15 minutes, add thickening agent, stir 20 minutes, measure the pH value of solution, slowly add acidity regulator, make the pH value of solution be 6-7, finally add wetting agent extracting solution and stir 20 minutes, can reduce the sterilization bath foam of operative incision.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510931588.7A CN105342939A (en) | 2015-12-15 | 2015-12-15 | Disinfectant bath wash capable of reducing operative incision infection and preparation technology of disinfectant bath wash |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510931588.7A CN105342939A (en) | 2015-12-15 | 2015-12-15 | Disinfectant bath wash capable of reducing operative incision infection and preparation technology of disinfectant bath wash |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105342939A true CN105342939A (en) | 2016-02-24 |
Family
ID=55319108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510931588.7A Pending CN105342939A (en) | 2015-12-15 | 2015-12-15 | Disinfectant bath wash capable of reducing operative incision infection and preparation technology of disinfectant bath wash |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105342939A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106267381A (en) * | 2016-07-12 | 2017-01-04 | 东莞市万佳医疗科技有限公司 | Body cavity imports lubricating fluid and preparation method thereof |
| CN108578272A (en) * | 2018-04-19 | 2018-09-28 | 山东顺皓聚氨酯保温材料有限公司 | A kind of polyhexamethylene guanide/biguanide hydrochloride shower cream and preparation method thereof |
| WO2019025599A1 (en) * | 2017-08-04 | 2019-02-07 | Laboratorios Kin, S.A. | Gel comprising chlorhexidine |
| CN109529025A (en) * | 2018-11-26 | 2019-03-29 | 浙江舒是生物科技有限公司 | A kind of medical cosmetology Special sterilizing liquid |
| CN111643519A (en) * | 2020-06-29 | 2020-09-11 | 华仁药业股份有限公司 | Wound disinfectant and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091097A (en) * | 2011-01-28 | 2011-06-15 | 武汉耦合医学科技有限责任公司 | Washing-free puerpera perineum medical-care gel and preparation method thereof |
| CN102100650A (en) * | 2011-01-28 | 2011-06-22 | 武汉耦合医学科技有限责任公司 | Gel medical supply for preventing bedsore and preparation method thereof |
| CN102107013A (en) * | 2011-01-28 | 2011-06-29 | 武汉耦合医学科技有限责任公司 | Sterile ultrasound gel for invasive ultrasound diagnosis and treatment and preparation method thereof |
| CN103271834A (en) * | 2013-06-18 | 2013-09-04 | 中国日用化学工业研究院 | Non-irritant pollution-free moisturizing pearly lustre bath foam and preparation method thereof |
| CN104784164A (en) * | 2015-03-13 | 2015-07-22 | 天津司邦适生物科技股份有限公司 | Protein-based skin cleaning disinfectant and preparation method thereof |
-
2015
- 2015-12-15 CN CN201510931588.7A patent/CN105342939A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091097A (en) * | 2011-01-28 | 2011-06-15 | 武汉耦合医学科技有限责任公司 | Washing-free puerpera perineum medical-care gel and preparation method thereof |
| CN102100650A (en) * | 2011-01-28 | 2011-06-22 | 武汉耦合医学科技有限责任公司 | Gel medical supply for preventing bedsore and preparation method thereof |
| CN102107013A (en) * | 2011-01-28 | 2011-06-29 | 武汉耦合医学科技有限责任公司 | Sterile ultrasound gel for invasive ultrasound diagnosis and treatment and preparation method thereof |
| CN103271834A (en) * | 2013-06-18 | 2013-09-04 | 中国日用化学工业研究院 | Non-irritant pollution-free moisturizing pearly lustre bath foam and preparation method thereof |
| CN104784164A (en) * | 2015-03-13 | 2015-07-22 | 天津司邦适生物科技股份有限公司 | Protein-based skin cleaning disinfectant and preparation method thereof |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106267381A (en) * | 2016-07-12 | 2017-01-04 | 东莞市万佳医疗科技有限公司 | Body cavity imports lubricating fluid and preparation method thereof |
| WO2019025599A1 (en) * | 2017-08-04 | 2019-02-07 | Laboratorios Kin, S.A. | Gel comprising chlorhexidine |
| CN110996891A (en) * | 2017-08-04 | 2020-04-10 | 实验室金公司 | Gel comprising chlorhexidine |
| CN110996891B (en) * | 2017-08-04 | 2023-02-28 | 实验室金公司 | Gel comprising chlorhexidine |
| CN108578272A (en) * | 2018-04-19 | 2018-09-28 | 山东顺皓聚氨酯保温材料有限公司 | A kind of polyhexamethylene guanide/biguanide hydrochloride shower cream and preparation method thereof |
| CN109529025A (en) * | 2018-11-26 | 2019-03-29 | 浙江舒是生物科技有限公司 | A kind of medical cosmetology Special sterilizing liquid |
| CN111643519A (en) * | 2020-06-29 | 2020-09-11 | 华仁药业股份有限公司 | Wound disinfectant and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105342939A (en) | Disinfectant bath wash capable of reducing operative incision infection and preparation technology of disinfectant bath wash | |
| JP5103041B2 (en) | Biofilm formation inhibitor composition | |
| EP2023733B1 (en) | Low foaming enhanced biocidal hydrogen peroxide composition | |
| EP1683418B1 (en) | Compositions for hygienic hand disinfection and disinfectant handwashing | |
| US20110028546A1 (en) | Novel antimicrobial formulations incorporating alkyl esters of fatty acids and nanoemulsions thereof | |
| JP6951421B2 (en) | Water-soluble antibacterial composition | |
| EP3133922B1 (en) | Improved biocide compositions based on calcium fluoride as well as uses thereof | |
| US9451777B2 (en) | Cleaning and sanitizing with antibacterial film | |
| WO2011161469A1 (en) | Disinfecting and sterilising solutions | |
| JP5075551B2 (en) | Biofilm production suppression method | |
| KR101500514B1 (en) | Wet Tissue Containing Antiseptic Composition without Skin Irritation | |
| CN106176333A (en) | A kind of preoperative patient sterilizes bath foam | |
| CN102037989B (en) | Aqueous compositions for disinfection and/or sterilization | |
| KR101476093B1 (en) | A composition for water tissue containing Piroctone olamine | |
| JP6715641B2 (en) | Aqueous bactericidal composition | |
| CN114376933A (en) | Antimicrobial composition for infant hand and mouth wet tissue and preparation method thereof | |
| CN111787903B (en) | Disinfectant composition | |
| JP2021102613A (en) | Antimicrobial composition | |
| JP2004352635A (en) | Composition for disinfection and/or sterilization | |
| CN113274327A (en) | Amino acid foam hand sanitizer and preparation method thereof | |
| EP3106172B1 (en) | Antimicrobial agents and their use | |
| CN112566619A (en) | Stable liquid composition for preserving cosmetic products containing PCA cocoyl arginine ethyl ester salt | |
| CN113244129A (en) | Antibacterial hand sanitizer and preparation method thereof | |
| JP2008100964A (en) | Biofilm formation inhibitor composition | |
| AU2022262205A1 (en) | Disinfectant and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160224 |